Landos Biopharma Key Fundamental Indicators
In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Landos Biopharma, as well as the relationship between them.
Analyzing historical trends in various income statement and balance sheet accounts from Landos Biopharma's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Landos Biopharma's valuation are summarized below:Landos Biopharma does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Landos |
Search Suggestions
| LA | Lagrange | Cryptocurrency |
| LANDP | Gladstone Land | Company |
| LAB | Standard Biotools | Company |
| LAARX | Laarx | Mutual Fund |
| LAG | SSgA | ETF |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Landos Biopharma has a Return On Asset of -0.3938. This is 95.5% lower than that of the Biotechnology sector and 98.33% lower than that of the Health Care industry. The return on asset for all United States stocks is 181.29% higher than that of the company.
Landos Biopharma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Landos Biopharma's current stock value. Our valuation model uses many indicators to compare Landos Biopharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Landos Biopharma competition to find correlations between indicators driving Landos Biopharma's intrinsic value. More Info.Landos Biopharma is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Landos Biopharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Landos Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Landos Biopharma's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Landos Biopharma could also be used in its relative valuation, which is a method of valuing Landos Biopharma by comparing valuation metrics of similar companies.Landos Biopharma is currently under evaluation in return on asset category among its peers.
Landos Fundamentals
| Return On Equity | -0.71 | |||
| Return On Asset | -0.39 | |||
| Current Valuation | 42.67 M | |||
| Shares Outstanding | 3.13 M | |||
| Shares Owned By Insiders | 9.88 % | |||
| Shares Owned By Institutions | 52.04 % | |||
| Number Of Shares Shorted | 1.43 K | |||
| Price To Book | 2.11 X | |||
| Price To Sales | 2.37 X | |||
| Gross Profit | 18 M | |||
| EBITDA | (22.73 M) | |||
| Net Income | (21.93 M) | |||
| Cash And Equivalents | 55.75 M | |||
| Cash Per Share | 1.38 X | |||
| Total Debt | 27 K | |||
| Current Ratio | 8.91 X | |||
| Book Value Per Share | 7.43 X | |||
| Cash Flow From Operations | (20.48 M) | |||
| Short Ratio | 0.08 X | |||
| Earnings Per Share | (4.00) X | |||
| Target Price | 12.71 | |||
| Number Of Employees | 19 | |||
| Beta | 0.14 | |||
| Market Capitalization | 71.68 M | |||
| Total Asset | 38.04 M | |||
| Retained Earnings | (155.36 M) | |||
| Working Capital | 31.79 M | |||
| Net Asset | 38.04 M |
Pair Trading with Landos Biopharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Landos Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Landos Biopharma will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to American Tower could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace American Tower when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back American Tower - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling American Tower Corp to buy it.
The correlation of American Tower is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as American Tower moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if American Tower Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for American Tower can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in Landos Stock
If you are still planning to invest in Landos Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Landos Biopharma's history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |